Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice
- 9 February 1993
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 231 (2) , 301-303
- https://doi.org/10.1016/0014-2999(93)90465-t
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Modulation of excitatory synaptic transmission by drugs that reduce desensitization at AMPA/kainate receptorsNeuron, 1991
- The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsyEuropean Journal of Pharmacology, 1991
- The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in miceEpilepsy Research, 1991
- Anticonvulsant activity of the NMDA antagonists, d(−)4-(3-phosphonopropyl)piperazine-2-carboxylic acid (D-CPP) and d(−)(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsyEpilepsy Research, 1990
- Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam.The Journal of Physiology, 1990
- 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a Neuroprotectant for Cerebral IschemiaScience, 1990